Actively Recruiting
Bright Light Therapy to Reduce Sleep Disturbance and Biological Aging in Lung Cancer Patients
Led by Henry Ford Health System · Updated on 2025-07-14
20
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
H
Henry Ford Health System
Lead Sponsor
M
Michigan State University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of bright light therapy on sleep disturbances and biological aging in lung cancer patients. The study aims to find out if daily bright light exposure can improve sleep patterns such as sleep onset latency, disturbance, and efficiency, and if it can slow aging measured by clinical biomarkers. The trial compares a group receiving bright light therapy to a control group with usual light exposure. Participants will be randomly assigned to one of two groups: one group will receive 30 minutes of bright light through a light visor daily for 4 weeks, while the other group will maintain their usual light exposure without bright light therapy. Blood samples will be collected at the start and after 4 weeks to assess biological age through clinical biomarkers. Throughout the study, participants will complete sleep, fatigue, and stress surveys at baseline and after 4 weeks, and keep a daily sleep log. Researchers will monitor changes in sleep patterns, biological age, fatigue, and stress. The trial lasts 4 weeks from enrollment to the end of the intervention.
CONDITIONS
Brief Title
Bright Light Therapy on Sleep Health in Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Diagnosed with stage Ib to IIIb primary lung cancer
- Completed primary therapy at least 2 months ago; maintenance or immunotherapy allowed
- ECOG performance status of 0 or 1
- Have problematic sleep with Insomnia Severity Index scores of 8 or higher
- Able to understand, speak, and read English
- Sighted and mentally competent to provide informed consent
You will not qualify if you...
- Pregnant women
- Have metastatic cancer
- Currently on oxygen therapy
- Diagnosed with seasonal affective disorder or substance abuse
- Engage in shift work or traveled across more than 3 time zones within 2 weeks prior to study
- Currently treated for sleep apnea, restless legs syndrome, or narcolepsy
- Take prescribed sedative hypnotics or antipsychotics
- Have eye conditions like glaucoma or retinal disease or problems triggered by bright light, or take photosensitizing medications
- Insomnia Severity Index score below 8
- Cognitive impairment with mini-cog test score below 3
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants in the bright light arm receive daily 30-minute exposure to 12,000 lux bright light through a light visor for 4 weeks. Participants in the control arm maintain their usual daily light exposure without bright light therapy.
Daily sessions for 4 weeks
Trial Site Locations
Total: 1 location
1
Henry Ford Health System
Detroit, Michigan, United States, 48202
Actively Recruiting
Research Team
M
Menghua Tao, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here